iiinova — where your digital self keeps evolving

Jonathan Lovell

@jflovell.bsky.social

125 followers 136 following 0 posts

SUNY Buffalo Biomedical Engineering. Western New York and Niagara.

Posts Replies Media

Reposted by Jonathan Lovell

Waggoner Lab @labwaggoner.bsky.social · 27/06/2026

A protein nanoparticle vaccine protects against seasonal influenza viruses, SARS-CoV-2, and RSV in animal models www.science.org/doi/10.1126/... @jflovell.bsky.social

082

Reposted by Jonathan Lovell

Eric Topol @erictopol.bsky.social · 04/05/2025

Front page @nytimes.com today 1 of 6 charts of the 1st 100 days www.nature.com/articles/s41...

10280115

Reposted by Jonathan Lovell

Chise @sailorrooscout.bsky.social · 22/04/2025

GOOD NEWS! Researchers at the University of Buffalo have developed a nanoparticle-based vaccine candidate for H5N1 avian influenza (clade 2.3.4.4b) that achieved 100% PROTECTION in preclinical trials. The vaccine is under development for potential use in BOTH veterinary AND human medicine. 🧪🧵⬇️

10549311459

Reposted by Jonathan Lovell

PLMcCarthyBuffalo @plmbuffalo.bsky.social · 19/04/2025

Highly pathogenic avian influenza H5N1 clade 2.3.4.4b hemagglutinin and/or neuraminidase elicit immunity in a recombinant nanoparticle vaccine: Cell Biomaterials www.cell.com/cell-biomate...

cell.com

Highly pathogenic avian influenza H5N1 clade 2.3.4.4b hemagglutinin and/or neuraminidase elicit immunity in a recombinant nanoparticle vaccine

CoPoP liposomes enable facile display of recombinant H5 and N1 derived from highly pathogenic avian influenza (HPAI), H5N1 clade 2.3.4.4b. With vaccination, mice elicited functional antibody responses...

011